Advertisement
Horizon Therapeutics To Buyback Up To $500 Mln Of Ordinary Shares
(RTTNews) - Biotechnology company Horizon Therapeutics plc (HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares.
Under the program, the Company may repurchase ordinary shares from time to time on the open market or through privately negotiated transactions or structured repurchase transactions.
As of June 30, 2022, the Company had cash and cash equivalents of $1.89 billion. The Company expects to fund the repurchase of its ordinary shares under the program with existing cash and cash equivalents.
read more
Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4
Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.
RTTNews
|
802天前
Horizon Says UPLIZNA Approved By Brazilian Health Regulatory Agency As Monotherapy For NMOSD
Biotechnology company Horizon Therapeutics plc (HZNP) announced Tuesday that the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.
RTTNews
|
1057天前
Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab
Biopharmaceutical company Xeris Biopharma Holdings, Inc. (XERS) announced Wednesday that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (HZNP).
RTTNews
|
1084天前
Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint
Horizon Therapeutics plc (HZNP) announced Monday that its Phase 2 trial evaluating dazodalibep for the treatment of Sjögren's syndrome met the primary endpoint in patients with moderate-to-high systemic disease activity. Sjögren's syndrome is a disease with no FDA-approved treatments available.
RTTNews
|
1156天前
Yen Falls Against Majors
The Japanese yen weakened against other major currencies in the Asian session on Wednesday.
RTTNews
|
1小时36分钟前
European Shares Seen Mostly Higher At Open
European stocks are seen opening broadly higher on Wednesday as traders hope for the end of the longest government shutdown in U.S. history.
RTTNews
|
3小时10分钟前
European Economic News Preview: Germany Final Inflation Data Due
Final inflation from Germany and industrial production from Italy are due on Wednesday, headlining a light day for the European economic news. At 2.00 am ET, Destatis is scheduled to release Germany's final inflation data for October. The flash estimate showed that consumer price inflation is forecast to ease to 2.3 percent from 2.4 percent in September.
RTTNews
|
3小时12分钟前
Sensex, Nifty Extend Gains As IT Stocks Surge
Indian shares opened on a buoyant note Wednesday, with IT stocks surging amid positive global cues and on growing optimism over a potential trade deal with the United States.
RTTNews
|
4小时10分钟前
